This company has shut down. Center for Breakthrough Medicines is no longer operating — its last tracked round was a Corporate Round in 2022.
Explore the Startup GraveyardCenter for Breakthrough Medicines is an innovative cell and gene therapy focusing on contract development and manufacturing organization.
Center for Breakthrough Medicines has raised $350.0M in total funding. The most recent round was Corporate Round. The last funding was announced in January 2022.
Center for Breakthrough Medicines's investors include SK Holdings.
Center for Breakthrough Medicines is headquartered in King Of Prussia, United States.
Center for Breakthrough Medicines is an innovative cell and gene therapy focusing on contract development and manufacturing organization.
Center for Breakthrough Medicines is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Center for Breakthrough Medicines — Funding & Investors." VCBacked, January 10, 2022, https://www.vcbacked.co/company/center-for-breakthrough-medicines. Accessed August 15, 2026.
VCBacked. (2022). Center for Breakthrough Medicines — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/center-for-breakthrough-medicines
{{cite web |title=Center for Breakthrough Medicines — Funding & Investors |url=https://www.vcbacked.co/company/center-for-breakthrough-medicines |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated